Elsevier buys Arezzo clinical decision support tool
Medical and scientific publishing firm Elsevier has bought InferMed, the UK-based company that produces the Arezzo clinical decision support system widely used by GPs in New Zealand.
Arezzo technology supports clinicians in choosing the most appropriate treatment path for each patient by matching the appropriate evidence-based guidelines with patient information and evaluating best-practice options in the light of current patient and disease information.
InferMed clinical decision support systems are installed in several regional and national health systems that provide patient-facing self-care advice, such as the NHS's symptom checker, as well as supporting nurse triage telephone services including those provided by Medibank Health Solutions.
In New Zealand, InferMed has worked with the Best Practice Advocacy Centre (BPAC) to roll out Arezzo as a web-based system that is designed specifically to support general practice in the management of a patient's health through screening, risk assessment, management and referral.
Arezzo is integrated into the main practice management systems (PMSs) and BPAC estimates it is used by 90 per cent of Kiwi GPs. In the UK, it is integrated into EMIS, the market leading PMS.
The president of Elsevier Clinical Solutions, Jay Katzen, said the acquisition would bolster the company's set of point-of-care solutions. “InferMed will enhance our point-of-care decision support suite and provide additional capabilities to deliver better information where and when clinicians and patients have the need,” Mr Katzen said.
"In addition to integrating InferMed's technology into Elsevier's decision support suite, we are excited to support the great work InferMed does with its existing clients.”
Elsevier Clinical Solutions' suite includes embedded workflow and decision support, clinical reference and patient engagement, including ClinicalKey.
InferMed is headquartered in London and has employees in New Zealand, Australia and France. The acquisition is effective immediately and financial terms of the transaction were disclosed.
Posted in New Zealand eHealth